tiprankstipranks
Hansa Biopharma AB (SE:HNSA)
:HNSA
Sweden Market
HNSA
Hansa Biopharma AB
RESEARCH TOOLSreports

Hansa Biopharma AB (HNSA) Stock News & Sentiment

16 Followers
Premium
Company Announcements
Hansa Biopharma sets Q1 2026 earnings call and business update
4d ago
Hansa Biopharma Raises USD 30 Million via Convertible Notes to Back U.S. Imlifidase Launch
Premium
Company Announcements
Hansa Biopharma Raises USD 30 Million via Convertible Notes to Back U.S. Imlifidase Launch
23d ago
Hansa Biopharma to Present Commercial Strategy at Redeye Life Science Event
Premium
Company Announcements
Hansa Biopharma to Present Commercial Strategy at Redeye Life Science Event
1M ago
Hansa Biopharma to Spotlight Immunomodulatory Platform at DNB Carnegie Healthcare Conference
Premium
Company Announcements
Hansa Biopharma to Spotlight Immunomodulatory Platform at DNB Carnegie Healthcare Conference
1M ago
Hansa Biopharma leadership to spotlight growth strategy at LSX Investival USA
Premium
Company Announcements
Hansa Biopharma leadership to spotlight growth strategy at LSX Investival USA
1M ago
Hansa Biopharma to Spotlight Immunomodulatory Platform at Leerink Global Healthcare Conference
Premium
Company Announcements
Hansa Biopharma to Spotlight Immunomodulatory Platform at Leerink Global Healthcare Conference
1M ago
Imlifidase: Extended FDA Review Seen as Timing-Driven, Not Risk-Driven, Supporting Buy Rating on Strong Unmet-Need and Efficacy Profile
Premium
Ratings
Imlifidase: Extended FDA Review Seen as Timing-Driven, Not Risk-Driven, Supporting Buy Rating on Strong Unmet-Need and Efficacy Profile
1M ago
More SE:HNSA News >

HNSA News on the Web

Hansa Biopharma sets Q1 2026 earnings call and business update
TipRanks News
Neutral
Hansa Biopharma Raises USD 30 Million via Convertible Notes to Back U.S. Imlifidase Launch
TipRanks News
Bullish
Hansa Biopharma to Present Commercial Strategy at Redeye Life Science Event
TipRanks News
Neutral
Hansa Biopharma to Spotlight Immunomodulatory Platform at DNB Carnegie Healthcare Conference
TipRanks News
Neutral
Hansa Biopharma leadership to spotlight growth strategy at LSX Investival USA
TipRanks News
Neutral
Hansa Biopharma to Spotlight Immunomodulatory Platform at Leerink Global Healthcare Conference
TipRanks News
Bullish
Imlifidase: Extended FDA Review Seen as Timing-Driven, Not Risk-Driven, Supporting Buy Rating on Strong Unmet-Need and Efficacy Profile
TipRanks News
Bullish
Hansa Biopharma Secures FDA PDUFA Date for Imlifidase in High-Risk Kidney Transplant Patients
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
SE:HNSA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SE:HNSA’s Media Buzz Sentiment?
1 articles about SE:HNSA were published this week. In an average week, 1 articles are published.
    What is SE:HNSA’s weekly average amount of articles?
    In an average week, 1 articles about SE:HNSA are published.
      What is SE:HNSA’s News Sentiment?
      50% of articles about SE:HNSA were positive this week, compared to its sector average of 59%.
        General Stocks that are Trending in the News
        SZYCFSaizeriya Co
        ENWEnwave Corp
        0RJIAnheuser Busch InBev SA/NV
        PAYPPayPay Corporation
        THXThor Explorations
        Showing the stocks with the most bullish news sentiment over the past week